Brainomix, a pioneer in stroke artificial intelligence (AI) imaging solutions, and 3DR Labs, the market leader in medical imaging post-processing services, announced a new strategic partnership to support acute stroke care in the US through the clinically validated and FDA-cleared Brainomix 360 Stroke.
Brainomix 360 Stroke is a comprehensive platform powered by the most advanced AI algorithms, unlocking expert-level insights that can enhance treatment decisions. Brainomix 360 is the only stroke AI imaging tool with a demonstrated impact on stroke treatment rates, with results from the largest real-world evaluation of stroke AI indicating a more than 50% increase in mechanical thrombectomy rates where the Brainomix software was clinically adopted.
3DR Labs specializes in high-quality 3D and advanced post-processing services for medical imaging, as well as clinical AI workflow solutions. With a team of over 250 certified and registered radiologic technologists, 3DR delivers complex image reconstructions quickly, accurately, and cost-effectively – supporting radiologists, radiologic technologists, and clinicians in providing top-notch patient care.
Also Read: RADPAIR and Lifetrack Announce Strategic Partnership to Revolutionize Radiology Workflow and Global Access
This partnership complements 3DR Labs’ recent launch of its Neurology Center of Excellence – a dedicated division focused on providing specialized post-processing services for stroke, pre-surgical planning, and the management of brain and spine diseases. The Center is staffed by highly trained radiologic technologists who have achieved 3DR’s proprietary Code Stroke Certification, ensuring consistent quality and clinical expertise in neuroimaging. Additionally, health systems can also leverage 3DR’s AI Labs, an all-in-one clinical workflow solution that combines AI with integrated human intelligence. This platform streamlines clinicians’ access to crucial imaging insights, further driving quality, speed, and efficiency within medical imaging workflows.
“We are delighted to announce this partnership with 3DR Labs across the US, who have an impressive track record of providing best-in-class products and service for their customers. Our teams now have an opportunity to deliver a comprehensive and seamless solution that can help stroke teams optimize the delivery of the care they provide to patients,” said Dr Michalis Papadakis, CEO and Co-Founder of Brainomix.
“Our collaboration with Brainomix enhances the ability to quickly and accurately assess patient eligibility for interventions like thrombectomy based on stroke severity,” stated Dr. Rob Falk, Founder, Neuroradiologist, and Chief Medical Officer of 3DR Labs. “Together, we are delivering a streamlined, all-in-one stroke solution for radiology and neurology teams.”
“We are excited to partner with Brainomix to deliver a comprehensive AI-driven solution for stroke care,” said Mike Jackman, CEO of 3DR Labs. “By integrating Brainomix into 3DR’s AI Labs – a cutting-edge vendor-agnostic platform that fits seamlessly into any clinical workflow – we’re expanding access to validated, high-impact stroke decision-support tools. This collaboration enables faster turnaround times and supports clinicians in reducing time-to-treatment, ultimately improving patient outcomes.”
SOURCE: PRNewswire